
Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
APNHY | OTC Markets | USD | Delayed | |
APNJ | Johannesburg | ZAR | Delayed |
Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and markets specialty and branded pharmaceutical products in Africa, the Middle East, the Americas, Europe CIS, Australasia, and Asia. It operates through Commercial Pharmaceuticals and Manufacturing segments. The company offers injectables for therapeutic areas, such as anaesthetics, anticoagulants, antithrombotic agents, analgesics, and hormone replacement medicines under the Arixtra, Diprivan, Fraxiparine, Marcaine, Sustanon, and Xylocaine brands; over-the-counter medicines under the Emla, Maltofer, Ovestin, Solpadeine, and Xylocaine brands; and prescription products for anti-inflammatories, immunosuppressants, hypothyroidism, anti-gout, analgesics, and corticosteroids under the Eltroxin, Imuran, Lipitor, Lyrica, and Zyloric brands. It also manufactures active pharmaceutical ingredients, finished dose forms, and heparins, as well as steriles, oral solid doses, liquids, semi-solids, and biologicals. The company exports its products. Aspen Pharmacare Holdings Limited was founded in 1850 and is headquartered in Durban, South Africa.
Name | Age | Since | Title |
---|---|---|---|
Kuseni Douglas Dlamini | 54 | 2012 | Independent Non-Executive Chairman |
Stephen Bradley Saad | 57 | 1999 | Group CEO & Executive Director |
Sean M. Capazorio | 55 | 1999 | Group CFO & Executive Director |
David Simon Redfern | 58 | 2015 | Non-Executive Director |
Christopher Nattle Mortimer | 63 | 1999 | Non-Executive Director |
Linda de Beer | 55 | 2018 | Independent Non-Executive Director |
Neo Phakama Dongwana | 52 | 2024 | Independent Non-Executive Director |
Themba Moyeni Mkhwanazi | 54 | 2019 | Independent Non-Executive Director |
Yvonne G. Muthien | 68 | 2021 | Independent Non-Executive Director |
Ben J. Kruger | 64 | 2019 | Lead Independent Non-Executive Director |
Reginald Haman | 49 | 2023 | Group Chief Corporate Officer & Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review